Secreted therapeutics: monitoring durability of microRNA-based gene therapies in the central nervous system

The preclinical development of microRNA-based gene therapies for inherited neurodegenerative diseases is accompanied by translational challenges. Due to the inaccessibility of the brain to periodically evaluate therapy effects, accessible and reliable biomarkers indicative of dosing, durability and...

Descripción completa

Detalles Bibliográficos
Autores principales: Sogorb-Gonzalez, Marina, Vendrell-Tornero, Carlos, Snapper, Jolanda, Stam, Anouk, Keskin, Sonay, Miniarikova, Jana, Spronck, Elisabeth A, de Haan, Martin, Nieuwland, Rienk, Konstantinova, Pavlina, van Deventer1, Sander J, Evers, Melvin M, Vallès, Astrid
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093922/
https://www.ncbi.nlm.nih.gov/pubmed/34704020
http://dx.doi.org/10.1093/braincomms/fcab054

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8093922/
https://www.ncbi.nlm.nih.gov/pubmed/34704020
http://dx.doi.org/10.1093/braincomms/fcab054

Ejemplares similares